Hematology NewsPadua variant factor IX gene shines in AMT-061February 25, 2019Bleeding DisordersGene Therapy
Oncology PracticeCMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Practice ManagementBusiness of MedicineTransplantationImmuno-oncologyImmunotherapyGene Therapy
Hematology NewsInvestigational gene therapy shows promise in hemophilia AJanuary 18, 2019Bleeding DisordersGene Therapy
Hematology NewsGO-8: Early promise for novel FVIII variant in hemophilia ADecember 20, 2018Bleeding DisordersGene Therapy
Hematology NewsFactor IX expression stable at up to 8 years with gene therapyDecember 5, 2018Bleeding DisordersGene Therapy
Hematology NewsNew treatments promise sickle cell “cure” for all agesDecember 1, 2018AnemiaGene Therapy
Hematology NewsSickle cell disease phenotype reversed by gene therapyDecember 1, 2018AnemiaGene Therapy
Hematology NewsSickle cell disease gene therapy seen advancingOctober 31, 2018AnemiaBleeding DisordersGene Therapy
Hematology NewsFeds aim to streamline gene therapy oversightAugust 16, 2018Practice ManagementImmuno-oncologyCellular TherapyBleeding DisordersBusiness of MedicineGene Therapy
Hematology NewsPayers part of the drug-pricing problem, says FDA commissionerMarch 7, 2018Practice ManagementBusiness of MedicineGene Therapy
Hematology NewsGenetic therapy lowers joint bleeding in hemophilia BJune 16, 2016Bleeding DisordersGene Therapy
